Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-24-287051
Filing Date
2024-12-31
Accepted
2024-12-31 06:04:00
Documents
18
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d917394d10qa.htm   iXBRL 10-Q/A 43809
2 EX-31.1 d917394dex311.htm EX-31.1 3243
3 EX-31.2 d917394dex312.htm EX-31.2 3210
  Complete submission text file 0001193125-24-287051.txt   319275

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA scph-20240930.xsd EX-101.SCH 5729
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20240930_cal.xml EX-101.CAL 996
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20240930_def.xml EX-101.DEF 14061
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20240930_lab.xml EX-101.LAB 19084
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20240930_pre.xml EX-101.PRE 15177
20 EXTRACTED XBRL INSTANCE DOCUMENT d917394d10qa_htm.xml XML 7877
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38293 | Film No.: 241591070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)